Assessing the utilization of radiotherapy near end of life at a Finnish University Hospital: a retrospective cohort study

Acta Oncologica
Liisa K RautakorpiSirkku M Jyrkkiö

Abstract

Palliative radiotherapy can improve quality of life for cancer patients during the last months of life. However, very short life expectancy may devastate the benefit of the treatment. This single center study assesses the utilization of radiotherapy during the last weeks of life. All cancer patients (N = 38,982) treated with radiotherapy (N = 11,395) in Turku University Central Hospital during 2005-2013 were identified in the database consisting of electronic patient records. One fourth (N = 2904, 25.5%) of the radiotherapy treatments were given during the last year of life. The last radiotherapy treatments and the time from the last radiotherapy treatment to death were assessed in regards to patients' age, cancer diagnosis, domicile, place of death and the treatment year. Treatments given during the last two weeks of life were also assessed regarding the goal of treatment and the reason for possible discontinuation. The median time from the last fraction of radiotherapy to death was 84 d. During the last two weeks before death (N = 340), pain (29.4%) was the most common indication for radiotherapy. Treatment was discontinued in 40.6% of the patients during the last two weeks of life, and worsening of general condition was the ...Continue Reading

References

Jan 15, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Craig C EarleJane C Weeks
Apr 30, 2005·Journal of Palliative Medicine·N A Janjan
Jun 30, 2005·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Craig C EarleJohn Z Ayanian
Mar 21, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Yvette M van der LindenUNKNOWN Dutch Bone Metastasis Study Group
Oct 26, 2007·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Dirk RadesJuergen Dunst
Jan 12, 2008·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Dirk RadesJochen Dahm-Daphi
Feb 1, 2011·International Journal of Radiation Oncology, Biology, Physics·Stephen LutzUNKNOWN American Society for Radiation Oncology (ASTRO)
Mar 16, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thi H HoCraig C Earle
Jun 15, 2011·Clinical Oncology : a Journal of the Royal College of Radiologists·K DennisE Chow
Nov 22, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B Ashleigh GuadagnoloYa-Chen Tina Shih
Aug 15, 2013·Journal of Oncology Practice·James D MurphyQuynh-Thu Le
Jan 11, 2014·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·B BergerD Zips
Jul 22, 2014·CA: a Cancer Journal for Clinicians·Joshua A JonesPeter A Johnstone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Duodecim; lääketieteellinen aikakauskirja
L TeppoB Söderman
International Journal of Radiation Oncology, Biology, Physics
Tarita O ThomasBharat B Mittal
Farmacia hospitalaria : órgano oficial de expresión científica de la Sociedad Española de Farmacia Hospitalaria
Pilar Taberner BonastreMaría Dolores Pérez-Serrano Lainosa
© 2022 Meta ULC. All rights reserved